Corporate Banner
Satellite Banner
Technology Networks Header
Friday, November 28, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Simultaneous Determination of Lithium, Sodium, and Calcium in Lithium Carbonate
Thursday, October 02, 2014
Thermo Fisher Scientific has developed an ion chromatography (IC)-based method to simultaneously determine lithium, sodium, and calcium in lithium carbonate without handling hazardous reagents.

Phenomenex Kinetex® EVO Core-Shell HPLC Columns
Wednesday, October 01, 2014
Deliver improved results and stability from pH 1 to 12.

Agilent Technologies’ Next-Generation UHPLC System
Tuesday, September 30, 2014
The 1290 Infinity II LC system sets new benchmark in laboratory efficiency.

Phenomenex Expands its Aeris® PEPTIDE Core-Shell Column Line
Thursday, September 18, 2014
The line now includes a 5 µm particle size for small-scale purifications.

Enhance Sample Preconcentration and Reduce Workflow
Thursday, September 18, 2014
New method developed by Thermo Fisher Scientific using solid-phase extraction well plates.

New Nexera-e Two Dimensional Comprehensive Liquid Chromatograph from Shimadzu
Wednesday, September 17, 2014
The system empowers laboratories to separate even the most complex mixtures.

Rapid & Simple SPE Methods Development
Tuesday, September 16, 2014
The Development Microlute™ enables simple and rapid screening to achieve your sample preparation objectives.

Quickly Identify Rhodamine B in Cosmetics
Friday, September 12, 2014
Determination of Rhodamine B using a rapid separation liquid chromatography column.

Agilent Introduces Next-Generation UHPLC System
Friday, September 12, 2014
Company will introduce its latest innovation on Sept. 23 at Analytica China in Shanghai.

<< 1 2 3 4 5 6 7 >>
Showing Results 21 - 30 of 795
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
SELECTBIO
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv